Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects-Reference-Cited by-同舟云学术

Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects

Published:2022-07-19 Issue:7 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Rodvold Keith A.¹^ORCID,Gotfried Mark H.¹²,Gupta Vipul³^ORCID,Ek Amanda³,Srivastava Praveen³,Talley Angela³,Bruss Jon³

Affiliation:

1. University of Illinois—Chicago, Chicago, Illinois, USA

2. Pulmonary Associates, PA, Phoenix, Arizona, USA

3. Spero Therapeutics, Inc., Cambridge, Massachusetts, USA

Abstract

Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an oral carbapenem prodrug being developed for the treatment of serious bacterial infections. The active moiety, tebipenem, has broad-spectrum activity against commonEnterobacteralespathogens, including extended-spectrum-β-lactamase (ESBL)-producing multidrug-resistant strains.

Funder

DHHS Office of the Secretary, BARDA

Spero Therapeutics

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.00590-22

Reference30 articles.

1. Tebipenem, the first oral carbapenem antibiotic

2. Characterization of SPR994, an Orally Available Carbapenem, with Activity Comparable to Intravenously Administered Carbapenems

3. Tebipenem pivoxil hydrobromide—No PICC, no problem!

4. Antimicrobial Activity Evaluation of Tebipenem (SPR859), an Orally Available Carbapenem, against a Global Set of Enterobacteriaceae Isolates, Including a Challenge Set of Organisms

5. In Vitro and In Vivo Characterization of Tebipenem, an Oral Carbapenem

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects;Antimicrobial Agents and Chemotherapy;2023-07-18

2. Novel Antimicrobial Agents for Gram-Negative Pathogens;Antibiotics;2023-04-16